| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/12/23 | 16 : 00 | RNS Regulatory News | MaxCyte, Inc. MaxCyte Announces Retirement of Board Member | LSE:MXCT | Maxcyte Inc |
| 2024/12/20 | 01 : 26 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/12/19 | 00 : 31 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/12/11 | 02 : 16 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/12/11 | 02 : 12 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/12/09 | 21 : 29 | Alliance News |  MaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savings | LSE:MXCT | Maxcyte Inc |
| 2024/12/09 | 16 : 00 | RNS Regulatory News | MaxCyte, Inc. MaxCyte Streamlines Operations and Raises Guidance | LSE:MXCT | Maxcyte Inc |
| 2024/12/03 | 02 : 09 | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights and Block Listing Return | LSE:MXCT | Maxcyte Inc |
| 2024/11/29 | 00 : 05 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/11/29 | 00 : 05 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/11/19 | 18 : 49 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/11/08 | 23 : 41 | Alliance News | MaxCyte third-quarter profit falls amid surging costs | LSE:MXCT | Maxcyte Inc |
| 2024/11/07 | 16 : 00 | RNS Regulatory News | MaxCyte, Inc. Filing of 10Q form | LSE:MXCT | Maxcyte Inc |
| 2024/11/07 | 16 : 00 | RNS Regulatory News | MaxCyte, Inc. Third Quarter 2024 Financial Results | LSE:MXCT | Maxcyte Inc |
| 2024/11/07 | 06 : 05 | UK Regulatory | MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance | LSE:MXCT | Maxcyte Inc |
| 2024/11/06 | 22 : 43 | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 2024/11/04 | 22 : 23 | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 2024/10/31 | 21 : 05 | RNS Non-Regulatory | MaxCyte, Inc. Upcoming Investor Conferences | LSE:MXCT | Maxcyte Inc |
| 2024/10/31 | 16 : 00 | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 2024/10/18 | 17 : 24 | RNS Regulatory News | MaxCyte, Inc. Grant of Options and Restricted Stock Units | LSE:MXCT | Maxcyte Inc |
| 2024/10/15 | 21 : 05 | RNS Regulatory News | MaxCyte, Inc. MaxCyte Appoints Cynthia Collins to Board | LSE:MXCT | Maxcyte Inc |
| 2024/10/11 | 21 : 00 | RNS Regulatory News | MaxCyte, Inc. Notice of Results | LSE:MXCT | Maxcyte Inc |
| 2024/10/10 | 21 : 05 | RNS Regulatory News | MaxCyte, Inc. MaxCyte Appoints Ali Soleymannezhad as CCO | LSE:MXCT | Maxcyte Inc |
| 2024/10/03 | 17 : 41 | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 2024/10/01 | 17 : 47 | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
| 2024/10/01 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 2024/09/28 | 00 : 15 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/09/27 | 23 : 29 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/09/21 | 01 : 02 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 2024/09/16 | 18 : 33 | Alliance News | MaxCyte touts strategic platform license deal with Kamau Therapeutics | LSE:MXCT | Maxcyte Inc |